SOLX Gold Shunt for Refractory Glaucoma

Conditions

Glaucoma | Glaucoma, Open Angle

What is the purpose of this trial?

To establish the clinical performance of the SOLX Gold Shunt for its ability to reduce intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed.



Participation Guidelines

Age:
21 Years - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
SOLX, Inc.
Dates:
January 2011
Last Updated:
January 14, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT01282346